If clinical trials are successful, Sinopharm’s new vaccine could join O jabs being developed by BioNTech, Moderna.
Hong Kong could have 3 Omicron-targeting jabs by end of year, as health expert reveals Sinopharm hopes to make new vaccine available by December
Share this: